Version 1
: Received: 29 January 2023 / Approved: 31 January 2023 / Online: 31 January 2023 (06:26:20 CET)
How to cite:
Rahman, M.T.; Rahman, H.; Shad, A. Dosing Schedule Modification of COVID-19 Vaccine in Immunosuppressed and Cancer Patient: A Review of Current Suggestions. Preprints2023, 2023010576. https://doi.org/10.20944/preprints202301.0576.v1
Rahman, M.T.; Rahman, H.; Shad, A. Dosing Schedule Modification of COVID-19 Vaccine in Immunosuppressed and Cancer Patient: A Review of Current Suggestions. Preprints 2023, 2023010576. https://doi.org/10.20944/preprints202301.0576.v1
Rahman, M.T.; Rahman, H.; Shad, A. Dosing Schedule Modification of COVID-19 Vaccine in Immunosuppressed and Cancer Patient: A Review of Current Suggestions. Preprints2023, 2023010576. https://doi.org/10.20944/preprints202301.0576.v1
APA Style
Rahman, M.T., Rahman, H., & Shad, A. (2023). Dosing Schedule Modification of COVID-19 Vaccine in Immunosuppressed and Cancer Patient: A Review of Current Suggestions. Preprints. https://doi.org/10.20944/preprints202301.0576.v1
Chicago/Turabian Style
Rahman, M.T., Homayra Rahman and Ashrak Shad. 2023 "Dosing Schedule Modification of COVID-19 Vaccine in Immunosuppressed and Cancer Patient: A Review of Current Suggestions" Preprints. https://doi.org/10.20944/preprints202301.0576.v1
Abstract
The effect of SARS-CoV-2 pandemic has been subsided significantly following the rapid development of vaccine. However, patients with cancer and immunosuppressed state, who are more prone to mortality and morbidity due to this infection, were excluded from majority of the vaccine trials. Moreover, suggested dose modification for cancer and immunosuppressed patients are often not followed because of lack of awareness or unavailability of vaccination schedule. This review will try to bridge this knowledge gap by summarizing the current suggestions of dose modification of COVID-19 vaccine for patients with cancer and immunosuppression.
Medicine and Pharmacology, Medicine and Pharmacology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
